Liang-Chih Liu
Overview
Explore the profile of Liang-Chih Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chien Y, Wu J, Liu L, Yu Y
Cell Death Discov
. 2025 Mar;
11(1):85.
PMID: 40038276
Breast cancer metastasis to the brain, occurring in about 15-25% of cases, represents a major obstacle in the treatment of triple-negative breast cancer (TNBC). The molecular mechanisms driving this form...
2.
Gao S, Lin T, Liu L, Chen W, Liang J
Breast Cancer Res
. 2024 Dec;
26(1):181.
PMID: 39695713
Background: Intraoperative radiotherapy (IORT) is a convenient treatment techniques for patients with early-stage breast cancer. We aimed to compare the outcome of IORT to that of whole-breast external beam radiotherapy...
3.
Kao Y, Tsai Y, Shen S, Dai M, Chen F, Liu L, et al.
J Chin Med Assoc
. 2024 Nov;
88(1):26-33.
PMID: 39528456
Background: Everolimus was the first orally targeted therapy for certain cancers. It was introduced before CDK4/6 inhibitors and is widely used to treat advanced hormone receptor-positive (HR+)/human epidermal growth factor...
4.
Tseng L, Chen F, Chen S, Cheng F, Chao T, Dai M, et al.
Oncol Res Treat
. 2024 Jul;
47(10):484-495.
PMID: 39033747
Introduction: This multicenter, phase II randomized, non-inferiority study reports from the first prospective two-armed randomized control trial that compared the efficacy, safety, and quality of life (QoL) of pegylated liposomal...
5.
Su M, Lin H, Nguyen H, Lin T, Chen C, Wang H, et al.
BMC Cancer
. 2024 Feb;
24(1):195.
PMID: 38347468
Background: Studies have shown that the absolute lymphocyte count (ALC) and the neutrophil-to-lymphocyte ratio (NLR) are related to the outcomes in patients with breast cancer receiving specific chemotherapies. However, the...
6.
Hua C, Chuang C, Chien Y, Su C, Chen S, Liu L, et al.
J Cell Mol Med
. 2023 Aug;
27(17):2594-2602.
PMID: 37581476
Head and neck squamous cell carcinomas (HNSCCs) are generally associated with tobacco consumption, alcohol abuse or both. Mucins (MUCs) are high-molecular-weight glycoproteins produced by many epithelial tissues. Many studies have...
7.
Lai H, Chen D, Liu L, Chen S, Kuo Y, Lin S, et al.
Ann Surg
. 2023 May;
279(1):138-146.
PMID: 37226826
Objective: To compare the clinical and patient-reported outcomes of minimal access and conventional nipple-sparing mastectomy (C-NSM). The secondary outcomes investigated included medical costs and oncological safety. Background: Minimal-access NSM has...
8.
Huang C, Liu L, Lu H, Shyr C
Biomedicine (Taipei)
. 2023 May;
13(1):13-21.
PMID: 37168728
Background: The porcine mammary glands share morphological and physiological similarities with human ones, making primary porcine mammary cells (PMC) suitable for biomedical research and a potential cellular therapeutic for breast...
9.
Hao X, Shen Y, Chen N, Zhang W, Valverde E, Wu L, et al.
Cell Stem Cell
. 2023 May;
30(5):648-664.e8.
PMID: 37146584
Remote tumors disrupt the bone marrow (BM) ecosystem (BME), eliciting the overproduction of BM-derived immunosuppressive cells. However, the underlying mechanisms remain poorly understood. Herein, we characterized breast and lung cancer-induced...
10.
Lin H, Lin C, Yeh T, Lin T, Yeh W, Yang L, et al.
BMJ Open
. 2023 Mar;
13(3):e059288.
PMID: 36927581
Objectives: This study aimed to compare the time required and concerns raised by various perspectives of participants regarding administering subcutaneous and intravenous trastuzumab for patients with breast cancer (BC). Design:...